Fundraising Fox

Timothy Morris

Investor

Venture Partner at LongeVC

About

Timothy Morris has held CFO and COO positions at pharmaceutical and biotech companies including Humanigen, Iovance Biotherapeutics (where he supported the approval of AMTAGVI, a cell therapy for solid tumors), AcelRx, VIVUS, and Questcor Pharmaceuticals. Across eight companies he has raised over $2.7 billion in equity and convertible securities, including two IPOs, and executed more than 100 strategic transactions totaling $5.7 billion. His experience covers capital formation, commercial strategy, manufacturing, and business development, including drug approvals and launches such as QSYMIA and DSUVIA.

Contact· self-published, not guessed

Invests in

Biotech

Investments

Board seats

Aquestive TherapeuticsDBV TechnologiesHumanetics CorporationUnivercells SA

Per the firm's website.

Colleagues at LongeVC

Frequently asked questions

Who is Timothy Morris?
Timothy Morris has held CFO and COO positions at pharmaceutical and biotech companies including Humanigen, Iovance Biotherapeutics (where he supported the approval of AMTAGVI, a cell therapy for solid tumors), AcelRx, VIVUS, and Questcor Pharmaceuticals. Across eight companies he has raised over $2.7 billion in equity and convertible securities, including two IPOs, and executed more than 100 strategic transactions totaling $5.7 billion. His experience covers capital formation, commercial strategy, manufacturing, and business development, including drug approvals and launches such as QSYMIA and DSUVIA.
Where does Timothy Morris work?
Timothy Morris is Venture Partner at LongeVC.
What does Timothy Morris invest in?
Timothy Morris invests in Biotech.
What boards does Timothy Morris sit on?
Timothy Morris holds tracked board seats at Aquestive Therapeutics, DBV Technologies, Humanetics Corporation, Univercells SA.